IBEX011, the first Nagoya-compliant GMP iboga extract, is now available for clinical use and academic research

/PRNewswire/ - Today, Terragnosis Inc., a Canadian drug development company, announced IBEX011, the first GMP extract of Tabernanthe iboga available for use in...

Related Keywords

Gabon ,Nagoya ,Aichi ,Japan ,Vancouver ,British Columbia ,Canada ,Canadian ,Gabonese ,Jonathan Dickinson ,Trevor Millar ,National Geographic ,E Association In Ebyeng ,Terragnosis Inc ,Ambio Life Sciences ,Chief Operations Officer Trevor ,Gabon Nagoya ,